Correlation Between Monopar Therapeutics and Direct Communication
Can any of the company-specific risk be diversified away by investing in both Monopar Therapeutics and Direct Communication at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Monopar Therapeutics and Direct Communication into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Monopar Therapeutics and Direct Communication Solutions, you can compare the effects of market volatilities on Monopar Therapeutics and Direct Communication and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Monopar Therapeutics with a short position of Direct Communication. Check out your portfolio center. Please also check ongoing floating volatility patterns of Monopar Therapeutics and Direct Communication.
Diversification Opportunities for Monopar Therapeutics and Direct Communication
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Monopar and Direct is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Monopar Therapeutics and Direct Communication Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Direct Communication and Monopar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Monopar Therapeutics are associated (or correlated) with Direct Communication. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Direct Communication has no effect on the direction of Monopar Therapeutics i.e., Monopar Therapeutics and Direct Communication go up and down completely randomly.
Pair Corralation between Monopar Therapeutics and Direct Communication
Given the investment horizon of 90 days Monopar Therapeutics is expected to generate 0.69 times more return on investment than Direct Communication. However, Monopar Therapeutics is 1.44 times less risky than Direct Communication. It trades about 0.23 of its potential returns per unit of risk. Direct Communication Solutions is currently generating about 0.14 per unit of risk. If you would invest 1,693 in Monopar Therapeutics on October 25, 2024 and sell it today you would earn a total of 2,239 from holding Monopar Therapeutics or generate 132.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.33% |
Values | Daily Returns |
Monopar Therapeutics vs. Direct Communication Solutions
Performance |
Timeline |
Monopar Therapeutics |
Direct Communication |
Monopar Therapeutics and Direct Communication Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Monopar Therapeutics and Direct Communication
The main advantage of trading using opposite Monopar Therapeutics and Direct Communication positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Monopar Therapeutics position performs unexpectedly, Direct Communication can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Direct Communication will offset losses from the drop in Direct Communication's long position.Monopar Therapeutics vs. Anebulo Pharmaceuticals | Monopar Therapeutics vs. Acrivon Therapeutics, Common | Monopar Therapeutics vs. Pmv Pharmaceuticals | Monopar Therapeutics vs. Molecular Partners AG |
Direct Communication vs. Crypto Co | Direct Communication vs. Datametrex AI Limited | Direct Communication vs. Atos SE | Direct Communication vs. Deveron Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |